Inventor · disambiguated record
Alexander Krantz
Also filed as: KRANTZ ALEXANDER
27 granted patents·8 pending applications·681 citations·filing 1984–2022
97Inventor score
Files withSYNTEX INC13KRANTZ ALEXANDER8CONJUCHEM INC5ADVANCED PROTEOME THERAPEUTICS INC3CORTRIA CORP3
Top patents by PatentIndex Score
35 records- 0197US4657893A4H-3,1-benzoxazin-4-ones and related compounds and use as enzyme inhibitorsSYNTEX INC·Filed 1984·Granted Apr 14, 1987·78 cites·40 claims
- 0295US6277863B1Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimesCONJUCHEM INC·Filed 2000·Granted Aug 21, 2001·43 cites·4 claims
- 0393US5055451AAryloxy and arylacyloxy methyl ketones as thiol protease inhibitorsSYNTEX INC·Filed 1987·Granted Oct 8, 1991·83 cites·50 claims
- 0488US6107489AExtended lifetimes in vivo renin inhibitorsCONJUCHEM INC·Filed 1999·Granted Aug 22, 2000·61 cites·15 claims
- 0586US7166695B2Affinity markers for human serum albuminCONJUCHEM BIOTECHNOLOGIES INC·Filed 2004·Granted Jan 23, 2007·19 cites·33 claims
- 0685US4745116A2-oxy-4H-3,1-benzoxazin-4-ones and related compounds and pharmaceutical useSYNTEX INC·Filed 1986·Granted May 17, 1988·23 cites·38 claims
- 0783US5840733AMethods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimesREDCELL CANADA INC·Filed 1996·Granted Nov 24, 1998·42 cites·18 claims
- 0882US11400165B2Composition and method for modifying polypeptidesADVANCED PROTEOME THERAPEUTICS INC·Filed 2018·Granted Aug 2, 2022·5 cites·11 claims
- 0982US5158936AAryloxy and arylacyloxy methyl ketones as thiol protease inhibitorsSYNTEX INC·Filed 1991·Granted Oct 27, 1992·44 cites·11 claims
- 1082US4912120A3,5-substituted 4,5-dihydroisoxazoles as transglutaminase inhibitorsSYNTEX INC·Filed 1987·Granted Mar 27, 1990·55 cites·32 claims
- 1181US4929630ATransglutaminase inhibitorsSYNTEX INC·Filed 1989·Granted May 29, 1990·49 cites·13 claims
- 1278US8927485B2Site-specific modification of proteins through chemical modification enabling protein conjugates, protein dimer formation, and stapled peptidesKRANTZ ALEXANDER·Filed 2011·Granted Jan 6, 2015·2 cites·9 claims
- 1376US4665070A2-oxy-4H-3,1-benzoxazin-4-ones and pharmaceutical useSYNTEX INC·Filed 1985·Granted May 12, 1987·24 cites·64 claims
- 1476US4602006AYnenolactone protease inhibitorsSYNTEX INC·Filed 1984·Granted Jul 22, 1986·9 cites·8 claims
- 1575US9545449B2Site-specific labeling and targeted delivery of proteins for the treatment of cancerADVANCED PROTEOME THERAPEUTICS INC·Filed 2013·Granted Jan 17, 2017·3 cites·16 claims
- 1675US6277583B1Affinity labeling libraries and applications thereofCONJUCHEM INC·Filed 1996·Granted Aug 21, 2001·49 cites·9 claims
- 1775US5942620AMethods for producing novel conjugates of thrombin inhibitorsCONJUCHEM INC·Filed 1998·Granted Aug 24, 1999·31 cites·19 claims
- 1873US9770515B2Crosslinking of proteins and other entities via conjugates of α-haloacetophenones, benzyl halides, quinones, and their derivativesKRANTZ ALEXANDER·Filed 2011·Granted Sep 26, 2017·1 cites·10 claims
- 1967US6403324B1Affinity labeling libraries with tagged leaving groupCONJUCHEM INC·Filed 1998·Granted Jun 11, 2002·32 cites·15 claims
- 2060US8431521B2Site-specific chemical modification of proteins at their N-termini, enabling the formation of homogeneous adductsKRANTZ ALEXANDER·Filed 2009·Granted Apr 30, 2013·0 cites·3 claims
- 2159US2023044430A1Composition and method for modifying polypeptidesKRANTZ ALEXANDER·Filed 2022·Application pending·0 cites
- 2258US2007259861A1Combination therapy with non-selective COX inhibitors to prevent COX-related gastric injuriesPHARMENA NORTH AMERICA INC·Filed 2007·Application pending·0 cites
- 2356US4668703Aγ-allenyl-γ-aminobutyric acidsSYNTEX INC·Filed 1985·Granted May 26, 1987·4 cites·20 claims
- 2456US2020095275A1Site-selective functionalization of proteins using traceless affinity labelsKRANTZ ALEXANDER·Filed 2019·Application pending·0 cites
- 2555US10329321B2Site-selective functionalization of proteins using traceless affinity labelsKRANTZ ALEXANDER·Filed 2017·Granted Jun 25, 2019·0 cites·3 claims
- 2655US6013792AMatrix metalloprotease inhibitorsSYNTEX INC·Filed 1995·Granted Jan 11, 2000·12 cites·22 claims
- 2752US2011263659A1Analogs of 1-MethylnicotinamideCORTRIA CORP·Filed 2009·Application pending·0 cites
- 2851US2011269724A1Combination Therapy with Non-Selective COX Inhibitors to Prevent COX-Related Gastric InjuriesCORTRIA CORP·Filed 2011·Application pending·0 cites
- 2950US2009118225A11-Methyl Nicotinamide and Derivatives for Treatment of Gastric InjuryCORTRIA CORP·Filed 2008·Application pending·0 cites
- 3050US2012108553A1Combination Therapy with Non-Selective COX Inhibitors to Prevent COX-Related Gastric InjuriesKRANTZ ALEXANDER·Filed 2011·Application pending·0 cites
- 3146US7927579B2Tandem analyses of noncovalently driven effectors for modulatory mapping of activities of protein sitesADVANCED PROTEOME THERAPEUTICS INC·Filed 2004·Granted Apr 19, 2011·0 cites·13 claims
- 3244US5773428AMatrix metalloprotease inhibitorsSYNTEX INC·Filed 1996·Granted Jun 30, 1998·4 cites·35 claims
- 3344US4661510Aα-allenic-α-amino acids as enzyme inhibitorsSYNTEX INC·Filed 1985·Granted Apr 28, 1987·2 cites·29 claims
- 3443US2013216479A1Site-specific chemical modification of proteins at their n-termini, enabling the formation of homogeneous adductsKRANTZ ALEXANDER·Filed 2013·Application pending·0 cites
- 3539US4873232ANovel use for carbamoyl benzoatesSYNTEX INC·Filed 1986·Granted Oct 10, 1989·6 cites·30 claims
Join the waitlist — get patent alerts
Get an alert when Alexander Krantz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →